Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

2019 Opioid Use Disorder Pre-PPS


Opioid Use Disorder:  A Collaborative Treatment Approach
 
ABOUT:  This course is designed to heighten awareness among healthcare professionals regarding the effects of the opioid epidemic, to enhance knowledge of the pharmacological and behavioral interventions used for treatment/recovery of opioid use disorder (OUD), and to increase motivation to provide access to medication-assisted recovery.  The activity will be delivered from a multidisciplinary, team-based perspective, to better explain the successful outcomes that are attainable when a variety of healthcare professionals contribute to the patient-centered treatment process.  With greater knowledge and expanded perspective of the treatment/recovery process, pharmacists will be prepared to actively engage in the fight against the opioid epidemic. This activity will provide attendees with clinical information that is relevant and easily applied in practice.  
 
FORMAT:  Before attending the LIVE activity, two brief assessments must be completed (not graded):
  • Module 1:  Pre-Course Assessment of Attitudes
  • Module 2:  Pre-Course Assessment of Knowledge

The LIVE activity will be divided into four sections and each section will include didactic and interactive case-based learning.  There will also be ample time built into the activity for participants to actively engage with the expert faculty practitioners, whose experience comes directly from their day-to-day practice as members of the multidisciplinary treatment team for patients recovering from opioid use disorder.  The faculty instructors are accustomed to treating the opioid epidemic at “ground zero” and they will share their knowledge and first-hand experiences to help other practitioners who also wish to take an active role in the opioid epidemic.  The live activity will conclude with an online Overall Evaluation, which must be completed to earn 3.5 hours of CE credit.


REGISTRATION:  Registration for this program is FREE!  Registration/attendance is separate from PPS or any other Pre-PPS program.  Please remember to have your NABP E-Profile ID to complete your registration.

Pre-PPS Evening Course DISCOUNT: Those attending the Pre-PPS Opioid Use Disorder program are eligible for a $20 discount on one of the EVENING Pre-PPS programs:  Sterile Compounding or Immunization Update (discount may not be applied to PPS registration).  To redeem the $20 discount, enter the following coupon code when registering for one of the EVENING Pre-PPS programs: hookem2019

CANCELLATIONS & NO-SHOWS:  Please call our office to cancel registration before September 1 if you no longer plan to attend.  Those who are registered but do not show up for the event will be billed $25 for program materials (if UT CPE not notified before September 1).


FINANCIAL DISCLOSURE & GRANT STATEMENT 
Development and availability of this course is supported in part by the Texas Health & Human Services Commission via an educational grant. A variety of survey data will be collected from participants to ensure programmatic quality and to assess effectiveness of curriculum. In the event that this data is analyzed for research purposes, participant responses remain confidential.
Faculty Financial Disclosures
See the activity tab below for presenters' disclosures.  

Off-Label Use of Medications
Content does not include off-lable use of medications

Participant Questions
Please send questions via email to UTpharmacyCE@austin.utexas.edu or call 512-471-6213.   
 

Date: Sep 13, 2019 12:30 PM - 04:30 PM

Fee

$0.00

CE Hours

3.50

CE Units

0.350

Registration closes on Sep 13, 2019 12:00 PM

Activity Type

  • Application

Target Audience(s)

  • Pharmacists
  • pharmacy technician

Accreditation(s)

“This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit.  The official record of credit may be located in the learner’s e-profile in CPE Monitor®.”
Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 3.5 contact hours (0.35 CEUs) of continuing education credit. In order to receive the full 3.5 hours of CE credit, the attendee must complete the two pre-course assessments (Modules 1 & 2), participate in all sessions of the LIVE activity, and complete the overall online evaluation at the end of the program.  CPE credit will be issued through CPE Monitor approximately 2 to 3 business days upon successful completion of the online evaluation.  Attendee must also verify that their correct NABP# and date of birth are entered into their profile.
 
ACPE UAN #:  0067-0000-19-108-L01-P/T

 

 

 

   

MODULE 1: Pre-Course Assessment of Attitudes
This pre-course survey will assess attitudes regarding content that will be presented in this course.

Release Date: Jul 12, 2019
Credit Expiration Date: Oct 1, 2019

   

   

MODULE 2: Pre-Course Assessment of Knowledge
This pre-course survey will assess knowledge of key concepts that will be covered in the course.

Release Date: Jul 12, 2019
Credit Expiration Date: Oct 1, 2019

   

   

Objectives

  • Identify FDA-approved medications for treatment of opioid use disorder (OUD)
  • Evaluate supportive behavioral interventions for treatment of opioid use disorder (OUD)
  • Identify how to provide patients access to medication-assisted recovery using FDA-approved medications

Speaker(s)/Author(s)

Carlos Tirado, M.D., M.P.H., F.A.B.A.M picture

Carlos Tirado, M.D., M.P.H., F.A.B.A.M
Founder and Owner, ABRI Integrated Health

Caroline Hedenberg, LCSW, LCSW
Collaborative Care Clinician, CARMAhealth

David Walsh, MSN, RN, PMHNP-BC, MSN, RN, PMHNP-BC
Chief Operations Officer, CARMAhealth

Lucas G Hill, PharmD, BCPS, BCACP picture

Lucas G Hill, PharmD, BCPS, BCACP
Director of Operation Naloxone, UT Austin College of Pharmacy

Activity Number

0067-0000-19-108-L01-P/T
Date: 09/13/19
Time: 12:30 PM - 04:30 PM

CE Hours

3.50
   

   

Date: 09/13/19
Time: 12:30 PM - 04:30 PM